Flat Open Even As Home Prices Rise


The markets opened flat with the Dow slipping 3 points to 16,203 even as single family home prices rose more than expected in December. Nasdaq eased a point to 4291. 

On the upside 

InterMune (Nasdaq: ITMN) reported positive results from a Phase 3 ASCEND trial of its idiopathic pulmonary fibrosis treatment pirfenidone.

The Food and Drug Administration granted DARA Biosciences (Nasdaq: DARA) Orphan Drug Designation for its chronic chemotherapy induced peripheral neuropathy treatment KRN5500.

Morgan Stanley lifted its price target on Tesla Motors (Nasdaq: TSLA) from $153 to $320.

On the downside

Office Depot (NYSE: ODP) widened fourth quarter losses more than expected. 

RealPage (Nasdaq: RP) reported lower fourth quarter earnings that fell short of expectations prompting a downgrade.

VIVUS (Nasdaq: VVUS) narrowed fourth quarter losses but concerns about sales of its obesity treatment Qsymia weighed down the stock price.

In the broad market, declining issues outpaced advancers by a margin of 9 to 7 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 edged down a point to 1845. Bitcoin lost $36.93 or 8.73% to $386.34.

About this Entry

This page contains a single entry by published on February 25, 2014 6:43 AM.

Upbeat News Lifts Markets was the previous entry in this blog.

Markets Flat As Confidence Slips is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12